ClinPhone and invivodata create a new global partnership to provide electronic patient reported outcomes (ePRO) solutions.
Nottingham, UK, and Pittsburgh, PA- April 30, 2008-ClinPhone ( www.clinphone.com ), the world’s largest Clinical Technology Organization and invivodata ( www.invivodata.com ), the leading provider of device-based eDiaries, announced today an exclusive new global partnership to provide electronic patient reported outcomes (ePRO) solutions.
This new partnership will deliver best-of-breed offerings for the two most commonly used ePRO modalities-device-based and IVRS (Interactive Voice Response System) to pharmaceutical and biotech companies. As part of this collaboration, ClinPhone joins invivodata’s PROPartner™ Program, which enables invivodata customers to leverage the strengths of an impressive roster of affiliate technology and service companies whose offerings have been identified as “best-in-class” in their respective market areas.
The alliance between these two industry leaders brings customers a combination of support and expertise that surpasses anything currently offered in the marketplace in terms of helping them understand which modality would be best suited for their study.
ClinPhone and invivodata both focus heavily on regulatory and psychometric validation issues. In addition, both companies have strong relationships with industry thought leaders and instrument authors, furthering the value that this partnership will bring to customers.
Doug Engfer, founder, president, and chief executive officer of invivodata stated, “Successful use of ePRO today requires an in-depth understanding of scientific and regulatory considerations, coupled with appropriate technology and complete global support services. invivodata and ClinPhone have collaborated on and shared in many of the same efforts, organizations and events designed to promote sound ePRO research. This formal partnership strengthens this collaboration and delivers real value and best-of-breed solutions to our clients.”
Steve Kent, chief executive officer of ClinPhone, commented, “Usage of PRO and ePRO in clinical trials is increasing. By offering invivodata’s device-based ePRO options to our customers, we can expand our ability to meet their broader ePRO needs. This partnership also means we are able to provide sponsors with additional balanced and science-based guidance in line with evolving regulatory considerations.”
ClinPhone ePRO is renowned as an industry-leading IVR-based solution and offers an intuitive and easy-to-use solution for capturing patient self-reported data. This ranges from simple diaries to sophisticated health-related quality of life instruments. invivodata’s device-based ePRO solutions are based on over 20 years of experience, combining the scientific and regulatory expertise needed for ePRO with practical technology and proactive services to deliver accurate and reliable PRO data to clinical trial sponsors.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Merck Stops HYPERION Trial for Winrevair in PAH Following Positive ZENITH Trial Results
January 30th 2025The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the efficacy of Winrevair (sotatercept-csrk) in treating pulmonary arterial hypertension, making it unethical to continue.